At a Glance
GreatPoint Ventures is a venture capital firm based in Cambridge, MA founded in 2003. GreatPoint Ventures is an early-stage venture capital firm based in San Francisco, California. The firm focuses on Pre-Seed, Seed, Series A, Series B+ investments across sectors including Aerospace & Defense, Digital Health, Other, Consumer, Fintech. Notable portfolio companies include Kala Pharmaceuticals, Millendo Therapeutics and Paratek Pharmaceuticals. Invests in early-stage healthcare and life sciences companies developing innovative technologies and therapeutics.
“Invests in early-stage healthcare and life sciences companies developing innovative technologies and therapeutics.”
Ashok Krishnamurthi
Managing Partner, GreatPoint Ventures
Avi Goldberg
Partner, GreatPoint Ventures
DJ Patil
General Partner, GreatPoint Ventures
Ray Lane
Managing Partner, GreatPoint Ventures
GreatPoint Ventures primarily invests at the Pre-Seed, Seed, Series A, Series B+ stages. This means they focus on companies that are at the earliest idea or prototype phase.
GreatPoint Ventures is headquartered in Cambridge, MA. Many of their portfolio companies are also based in this region, though they invest across geographies.
GreatPoint Ventures focuses on investments in Aerospace & Defense, Digital Health, Other, Consumer, Fintech. Their portfolio reflects deep expertise and networks within these sectors.
GreatPoint Ventures's typical investment check size ranges from $3M to $10M. Actual amounts may vary based on the stage, sector, and specific opportunity.
GreatPoint Ventures manages approximately $150M in assets under management (AUM) across their funds.